JPRN-UMIN000037739
Recruiting
未知
Identification of gene polymorphisms that predict the efficacy and safety of nivolumab treatment for renal cancer - SNiP-RCC
Graduate School of Medical Sciences, Kyushu University0 sites200 target enrollmentAugust 20, 2019
ConditionsRenal cell cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Renal cell cancer
- Sponsor
- Graduate School of Medical Sciences, Kyushu University
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.non\-Japanese patients 2\.Patients in whom the evaluation of response rate according to RECIST ver.1\.1 is not carried out within 24 weeks after the start of treatment 3\.Patients who received nivolumab as first line treatment 4\.Patients who co\-administered with drugs for renal cancer other than nivolumab 5\.Patients who are judged inappropriate for participation in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Analysis of gene polymorphisms reported to have influence on transplant outcome in recipients and donors of hematopoetic stem cell transplantsT86.0Bone-marrow transplant rejectionDRKS00004352Klinik für KMTUniklinik Essen200
Recruiting
Not Applicable
Elucidation of genes involved in individual differences in ondansetron sensitivityPatients undergoing orthognathic surgeryJPRN-UMIN000051727Tokyo Dental College100
Completed
Not Applicable
Analysis of genetic polymorphisms for predicting response to treatment and progression of prostate tumorJPRN-UMIN000009785Department of Urology, Akita University Graduate School of Medicine200
Not yet recruiting
Not Applicable
Genetics of margin-negative Oral Squamous Cell Carcinoma surgical resection.CTRI/2023/11/060253ICMR
Completed
Not Applicable
Genetic study to identify genetic variants which affect clinical severity in Thai patients with beta thalassemia hemoglobin Eclinical variation in patients with beta thalassemia Hb E diseasebeta thalassemia Hb E disease, Thailand, genetic modifierTCTR20211022001Siriraj Hospital338